(Date:11/30/2009)...Nov. 30 In Massachusett...ease are cared for at home, so the Alzheimer,s Ass...24/7 Helpline during the holiday season. For most ...or togetherness and sharing, but for a family deal...ul and filled with special challenges, according t...
(Date:11/30/2009)...strator Alonzo L. Fulgham ,, WASHINGTON, Nov. ... global community once again recognizes World AIDS...S worldwide. This is also a time to renew our com...demic and pay homage to the millions of people who...partner in the U.S. President,s Emergency Plan for...
(Date:11/30/2009)...PRNewswire-FirstCall/ - AIM Health Group Inc. ("AI...ted health care company, announced today that its ...ber 30, 2009 (the "Quarter") increased to $633,199...ame time EBITDA(1) increased 290% to $910,734 from...mpany also announced that revenues increased 87% t...
(Date:11/30/2009)... 30 Mary Rita Hyland, Assistant Vi...up, Inc., (SSI) has been elected to the 2010 Board... (WEDI). ,, Hyland has held a variety of leade...ion in 2001. She was initially charged with the de...division and Business Continuity for SSI. She late...
(Date:11/30/2009)...v. 30 A revolutionary new technolo...s, and patients with seamless, real-time access to... of a button was announced today by Candelis, Inc....nagement, visualization and workflow optimization ...y with the cumbersome and costly method of sharing...
Breaking Medicine News(10 mins):Health News:Alzheimer's Caregivers Face Holiday Stress 2Health News:USAID Recognizes World AIDS Day 2Health News:AIM Health Group Inc. continues increased quarterly profits 2Health News:AIM Health Group Inc. continues increased quarterly profits 3Health News:AIM Health Group Inc. continues increased quarterly profits 4Health News:SSI Assistant Vice President Elected to WEDI Board 2Health News:Candelis Announces Revolutionary Cloud-Hosted Data Services 2Health News:Candelis Announces Revolutionary Cloud-Hosted Data Services 3...e,which for most Americans means time spent in sto...h family and friends. All of this time spent,indoo...sk for contracting,viruses, particularly influenza...is sometimes deadly virus, but also to help,protec...
...; Adjusted EPS $0.47, CORONA, Calif., Oct. 29 Wa...g specialty pharmaceutical,company, today reported...tember 30, 2008., Third Quarter 2008 Results, Ne...ion, or $0.62 per diluted share. Excluding special...
...nd in early lactation would... Oct. 29 Current methods,for detecting and diagno...eds of dairy producers well, according to a survey...inarians,surveyed are responsible for nearly 2 mil...
...,s ADA Approved, 100%,Recycled EntryLevel(TM) Land...ct. 29 For nearly 40 million,of-voting-age Americ... just,a decision of who to vote for, rather, an is... to determine whether the,nearest polling center c...
...ay that it has been chosen to present at the 2008 ...r 30, 2008 to be held in New York City. , ...-- Curemark announced today that it has been cho...althcare Venture Summit presented by Young Startup...
...n addition to its roster of online degree programs...r 29, 2008 -- Gonzaga University ( www.gonzagaonli...based in Spokane, has announced the addition of a ...onal Leadership and Master of Science in Nursing. ...
Other Medicine News:Health News:Give the Gift of Good Health This Holiday Season - Remind Friends and Family to Get a Flu Shot 2Health News:Give the Gift of Good Health This Holiday Season - Remind Friends and Family to Get a Flu Shot 3Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 2Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 3Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 4Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 5Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 6Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 7Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 8Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 9Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 10Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 11Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 12Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 13Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 14Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 15Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 16Health News:Watson Pharmaceuticals Reports Third Quarter 2008 Results 17Health News:Dairy Veterinarians Highlight Need for Improved Methods for Detecting Mastitis 2Health News:SafePath(TM) Products Provides Universal Access for Ohio Voters 2Health News:Curemark to Present at the 2008 Life Sciences & Healthcare Venture Summit 2008 2Health News:Gonzaga Online Updates Communications Masters Program To Meet the Needs of Today's Professionals 2(Date:11/30/2009)..., , SAN CARLOS, Calif., Nov. 30 /PRNewsw...TR ) today announced the promotion of Lorianne Mas...cal Officer. Dr. Masuoka will report directly to ...ward W. Robin. ,, "Lorianne,s outstanding lea...strategies have been instrumental in rapidly advan...
(Date:11/30/2009)..., , BOTHELL, Wash., Nov. 30 /PRNewswire... ) announced today that on November 25, 2009, the ...y that it had accepted the Company,s plan to compl... under Section 1003(a)(iv) of the Exchange Company...d that the Company sustained losses which were so ...
(Date:11/30/2009)..., , NEW YORK, Nov. 30 /PRNewswire/ ...search report is available in its catalogue: ,,...lligence Report ,, http://www.reportlinker.co...rket-Intelligence-Report.html ,, Cardiovascul... deaths globally. Sudden cardiac arrest survivors ...
Breaking Medicine Technology:Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 2Nektar Therapeutics Promotes Lorianne Masuoka, M.D. to Senior Vice President and Chief Medical Officer 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 2SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 3SCOLR Pharma, Inc. Receives Notices From NYSE Amex LLC Regarding Compliance Plan and Listing Standards 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 2Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 3Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 4Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 5Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 6Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 7Reportlinker Adds Cardiac Defibrillators - A Worldwide Market Intelligence Report 8ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 1ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 2ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 3ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 4ICU Medical Inc to Acquire Hospiras Critical Care Product Line 51206 5Study identifies potential fix for damaged knees 51203 1Study identifies potential fix for damaged knees 51203 2Study identifies potential fix for damaged knees 51203 3European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 1European Health Care Institutions Forced to Select Lower Priced Interventional Cardiology Devices 51202 2...esults Prompted Phase 2 Study Now Underway at Nine...swire/ -- Ceregene,Inc., a biopharmaceutical comp... a Phase 1 clinical trial of CERE-120, a gene,ther...rkinson,s,disease, demonstrating a 36 percent (p<0...hs after administration, as measured,by the Unifie...
...ass., April 16, 2007 /PRNewswire-FirstCall/ --,Gen...ed study of,Renvela(TM) (sevelamer carbonate) achi...ically significant reduction in serum,phosphorus f...disease who are not on dialysis. , Patients treate...on in calcium-phosphorus product and in LDL choles...
Other Medicine Technology:Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 2Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 3Ceregene Presents Long Term Follow-Up Data From Phase 1 Trial of,CERE-120 Demonstrating Improved Motor Function in Parkinson's,Patients 4Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease 2Genzyme Announces Successful Completion of Study Investigating,Sevelamer Carbonate in Patients With Chronic Kidney Disease 3Cholesterol-5
Cholesterol Reagent
Omega 12ic
Genegnome Bio Imaging System for Chemiluminescence
Medicine Products: